All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.

All G's human lactoferrin will be bio-equivalent to the native form with greater than 95% purity. As the company's first recombinant human milk protein, it marks a step toward improving early life ...

THE antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a ...

SYDNEY — All G, a company using precision fermentation to develop recombinant proteins, has received self-affirmed GRAS (Generally Recognized As Safe) status for its recombinant bovine lactoferrin.

Biotechnology company Helaina is taking the next step in its mission to transform nutrition with human equivalent bioactive proteins by bringing its flagship ingredient – effera Human Lactoferrin – to ...

Synthetic biology specialist Conagen says it has come up with a cost effective way to produce lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk, a potential ...

The study has made evident that the administration of Lactoferrin shows promising efficacy in reducing the risk of RTIs, which is proven to be a key ingredient for our natural defence systems against ...

Baby formula is not, traditionally, a food synonymous with innovation. But Laura Katz, CEO of Helaina, is hoping to change that. Katz started her company, in 2019 in NYC, hoping to recreate breast ...

The global bovine lactoferrin market is poised for extraordinary expansion in the coming decade, driven by increasing demand and diverse applications across multiple industries. With an anticipated ...